MN HF4577Introducedas of 2026-03-23
Psilocybin therapeutic use program established; protections for registered patients, registered suppliers, registered facilitators, and health care practitioners established; civil actions authorized; advisory committee established; and money appropriated.
Plain-English summary
What happened: This Minnesota bill would establish a psilocybin therapeutic use program with protections for patients, suppliers, and facilitators, and appropriate funding, but has been recalled and re-referred to the Veterans and Military Affairs Division.
Why it matters: The re-referral introduces additional procedural steps, affecting the timeline for suppliers and facilitators seeking to operate under a regulated psilocybin framework.
Affects: cultivators and retailers and patients
LATEST ACTION: Motion to recall and re-refer, motion prevailed Veterans and Military Affairs Division
READ THE FULL BILL TEXT →Follow Minnesota cannabis bills for free. One plain-English email a week with every bill that moved, including this one.
Get the free digestMore Minnesota cannabis bills
SF4401Omnibus Cannabis billPassedSF4957Registered designated caregivers provisions modifications and increasing patient and cannabis plant limits expansion provisionIntroducedHF3615Cannabis laboratory testing requirements extended.PassedSF4876Cannabis microbusiness outdoor cultivation limit increaseIntroducedSF4875Medical cannabis endorsement requirements modificationIntroducedSF4877Cannabis license application periods and issuance modificationIntroducedSF4871Remediated cannabis product definitionIntroducedHF4733Remediated cannabis product defined, and cannabis business required to disclose information related to remediated cannabis products.Introduced
ALL MINNESOTACANNABIS LAWS & BILLS →Legislative data via LegiScan, licensed under CC BY 4.0. Summaries and categorization by CannaSignal. Regulatory information, not legal advice.